...
首页> 外文期刊>Anesthesia and Analgesia: Journal of the International Anesthesia Research Society >The Antihyperalgesic Effects of Intrathecal Bupropion, a Dopamine and Noradrenaline Reuptake Inhibitor, in a Rat Model of Neuropathic Pain
【24h】

The Antihyperalgesic Effects of Intrathecal Bupropion, a Dopamine and Noradrenaline Reuptake Inhibitor, in a Rat Model of Neuropathic Pain

机译:鞘内安非他酮,多巴胺和去甲肾上腺素再摄取抑制剂在神经性疼痛大鼠模型中的抗痛觉过敏作用

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Antidepressants are often used for the treatment of neuropathic pain, and their analgesic effects rely on increased noradrenaline and serotonin levels in the spinal cord. Clinical studies have also shown that bupropion, a dopamine and noradrenaline reuptake inhibitor, has strong efficacy in neuropathic pain; however, the role of spinal cord dopamine in neuropathic pain is unknown. We hypothesized that bupropion inhibits neuropathic pain by increasing noradrenaline and dopamine in the spinal cord. In the present study, we determined the efficacy and underlying mechanisms of intrathecal administration of bupropion in a rat model of neuropathic pain.
机译:背景:抗抑郁药通常用于治疗神经性疼痛,其镇痛作用取决于脊髓中去甲肾上腺素和血清素水平的升高。临床研究还表明,多巴胺和去甲肾上腺素再摄取抑制剂安非他酮在神经性疼痛中具有强大的功效。然而,脊髓多巴胺在神经性疼痛中的作用尚不清楚。我们假设安非他酮通过增加去甲肾上腺素和脊髓中的多巴胺来抑制神经性疼痛。在本研究中,我们确定了鞘内注射安非他酮在神经性疼痛大鼠模型中的功效和潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号